Current Agenda
Exact times are subject to change.
Wednesday, June 28, 2023
| Time | Event |
|---|---|
| 1:00–2:45 p.m. ET | Meeting Welcome and Opening Plenary Meeting Welcome from the National Institutes of Health (NIH) Meeting Objective and Overview Introduction of Opening Panel Pharmacists: Advancing Public Health The Role of Pharmacists in the U.S. National HIV/AIDS Strategy The U.S. EHE Pharmacist Task Force Building a Coalition of Pharmacies to Respond to HIV The U.S. Evidence Base for Pharmacy-Delivered HIV Services over the HIV Prevention and Care Continua Lessons from Global Research in Pharmacy-Based HIV Service Delivery Discussant Comment: Building on Our Accomplishments with Next Steps Questions for Opening Panel |
| 2:45–3:45 p.m. ET | Topic Panel One: Meeting Community Interests Across the Spectrum of Community Pharmacies — From Independent to Chain Opening Comments, Panel Introductions Community Independent Pharmacies: Furthering Innovation in Oral and Injectable PrEP Delivery Community Chain Pharmacies: Achieving Scale and Reach Discussant Comments: Meeting Community Interests Questions for the Panel |
3:45–5:00 p.m. ET
| Topic Panel Two: Advancing HIV Testing through Pharmacies Opening Comments, Panel Introductions Implementing Point of Care Testing and a Collaborative HIV Screening Program in Pharmacies Lessons Learned from HIV Screening Initiatives at CVS Health AmbassADDOrs for Health: A Community-Randomized Trial to Support HIV Testing and Contraception Access Among Young Women Through Drug Dispensing Shops in Tanzania Considering Pharmacy Locations and the Need to Bridge "Pharmacy Deserts" Panel Questions Close of Day One |
Thursday, June 29, 2023
| Time | Event |
|---|---|
| 1:00–2:20 p.m. ET | Topic Panel Three: Advancing HIV PrEP through Pharmacies Day Two Welcome Opening Comments, Panel Introductions The Iowa TelePrEP Program: Telemedicine + Pharmacists = PrEP Access and Use A Novel Community-Retail Pharmacy Partnership to Advance HIV PrEP Understanding the Implementation of SB159: Pharmacist Delivered Pre- and Post-exposure Prophylaxis in Three High HIV Incidence EHE Counties in California A Demonstration Project to Advance HIV PrEP Delivery Through Pharmacies Nurse-Facilitated PrEP Delivery for Adolescent Girls and Young Women Seeking Contraception at Retail Pharmacies in Kisumu, Kenya Questions for the Panel |
| 2:20–3:30 p.m. ET | Topic Panel Four: Advancing HIV Treatment through Pharmacies Opening Comments, Panel Introductions Supporting Adherence and Viral Suppression Through the Patient-centered HIV Care Model Project: A Data to Care Rx: Engaging Pharmacies and Pharmacists in Proactive Efforts to Retain People with HIV in Care Implementing Injectable HIV Treatment in an Ambulatory Infectious Diseases Clinic Through Pharmacists and Pharmacy Technicians Exploring Pharmacist and Pharmacy-Based Delivery of Long-Acting Injectable ART Questions for the Panel |
| 3:30–4:35 p.m. ET | Topic Panel Five: Addressing HIV Syndemic Factors and Co-Morbidities Through Pharmacies Opening Comment, Panel Speaker Introductions Improving Syringe Access, Opioid Overdose Prevention, and Naloxone Dispensation Among Rural and Rmall Influences on the Availability of Medications for Opioid Use Disorder in Outpatient and Inpatient Pharmacies in South Florida Advancing Mobile Pharmacies to Deliver PrEP/ART and Buprenorphine and Naloxone to People Who Use Drugs in Connecticut A Pharmacist-Delivered Primary Care Telemedicine Intervention to Increase Access to Pharmacotherapy A Pharmacist-Delivered Intervention to Address Smoking Cessation in People with HIV Questions for the Panel |
| 4:35–5:00 p.m. ET | Closing Session: Looking to the Future Opening Comment Bringing It All Together: Reflecting on Research Gaps and Opportunities Onward Idea Collection Note of Thanks Next Steps and Meeting Close |